CCL2, acting through pathways like PI3K/AKT and JAK/STAT, is crucial for macrophage and glioma cell migration [53–55], making it a potential target for tumor microenvironment modulation [56–58]. The gene discussed is CCL2; the disease is central nervous system cancer.